DOCS
Doximity, Inc.
NYSE · Healthcare · Medical - Healthcare Information Services · US
$26.35
−2.77%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 655.6M | 644.9M | 570.4M | 475.4M | 419.1M |
| Cost of Revenue | 78.2M | 70.3M | 55.9M | 50.7M | 53.5M |
| Gross Profit | 577.3M | 574.5M | 514.5M | 424.8M | 365.6M |
| Operating Expenses | |||||
| R&D Expense | 142.4M | 130.7M | 93.0M | 82.0M | 80.2M |
| SG&A Expense | 240.9M | 228.9M | 191.4M | 171.0M | 160.3M |
| General & Admin Expense | 68.6M | 65.3M | 45.7M | 37.8M | 36.7M |
| Selling & Marketing Expense | 172.3M | 163.6M | 145.7M | 133.1M | 123.5M |
| Other Expenses | — | — | 2.3M | 7.9M | — |
| Total Operating Expenses | 383.3M | 359.6M | 286.7M | 260.9M | 240.5M |
| Cost and Expenses | 461.5M | 429.9M | 342.6M | 311.5M | 293.9M |
| Operating Income (EBIT) | 194.0M | 214.9M | 227.8M | 163.9M | 125.1M |
| Non-Operating | |||||
| Interest Income | 32.8M | 35.7M | 35.9M | 21.7M | 9.3M |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | 32.8M | 35.7M | 35.9M | 21.7M | 9.3M |
| Other Non-Op Income/Expense | 32.2M | 35.1M | 35.8M | 21.3M | 8.0M |
| Non-Operating Income (excl Interest) | (32.2M) | (35.1M) | (2.3M) | (7.9M) | (8.0M) |
| EBT (Pre-Tax Income) | 226.2M | 250.0M | 263.6M | 185.2M | 133.2M |
| Income Tax Expense | 59.2M | 54.0M | 40.4M | 37.6M | 20.3M |
| Bottom Line | |||||
| Net Income | 167.0M | 196.1M | 223.2M | 147.6M | 112.8M |
| Earnings from Cont. Ops | 167.0M | 196.1M | 223.2M | 147.6M | 112.8M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 167.0M | 196.1M | 223.2M | 147.6M | 112.8M |
| Per Share | |||||
| Basic EPS | $0.89 | $1.05 | $1.19 | $0.78 | $0.58 |
| Diluted EPS | $0.85 | $0.98 | $1.11 | $0.72 | $0.53 |
| Revenue Per Share | $3.59 | $3.45 | $3.05 | $2.50 | $2.17 |
| Shares | |||||
| Basic Shares Outstanding | 182.6M | 187.0M | 186.8M | 190.2M | 193.2M |
| Diluted Shares Outstanding | 191.2M | 199.0M | 201.2M | 205.7M | 213.4M |
| Profitability Metrics | |||||
| EBITDA | 243.8M | 264.4M | 240.8M | 182.1M | 143.4M |
| D&A | 17.6M | 14.4M | 10.7M | 10.3M | 10.3M |
| EBIT | 226.2M | 250.0M | 230.1M | 171.8M | 133.2M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026